DrugInformations.org

Mark Heiner of Culver City reads books, paints artistically, takes walks and does laundry activities that would be considered routine except for the fact that a four-pound disk implanted in his abdominal cavity is keeping his blood flowing.The procedure to implant the Thoratec HeartMate XVE was performed in early March by a team led by cardiothoracic surgeon Sinan A. Simsir, M.D. [click link for full article]

More: continued here

No Comments »

Richard Idro, M.M.E.D., of the Kenya Medical Research Institute, Kilifi, Kenya and colleagues conducted a study to determine the incidence and neurological involvement of African children with acute falciparum malaria (a severe type of malaria). The study included 19,560 Kenyan children younger than 14 years with malaria. [click link for full article]

More: continued here

No Comments »

Tick-borne diseases, such as Lyme disease, have been increasing among New York City residents since 2003, and the Health Department today reminded New Yorkers to protect themselves against ticks when they are outdoors this summer. The vast majority of Lyme disease cases in New York City are acquired outside of the five boroughs, in areas where the type of tick that transmits Lyme disease (Ixodes scapularis) is found. There were 307 cases of Lyme disease reported in 2006. [click link for full article]

More: continued here

No Comments »

Programs for HIV-positive residents in three California counties are facing cuts in some services after HHS officials announced funding allocations that will result in an annual loss of $8.6 million in federal funds for the counties, the San Francisco Chronicle reports. [click link for full article]

More: continued here

No Comments »

Regulatory oversight of nanotechnology is urgently needed and the Environmental Protection Agency (EPA) should act now, reports a new study. In EPA and Nanotechnology: Oversight for the 21st Century, former EPA assistant administrator for policy, planning and evaluation, J. Clarence (Terry) Davies, provides a roadmap for a new EPA to better handle the challenges of nanotechnology. [click link for full article]

More: continued here

No Comments »

Treatment studies that exclude the homeless, illicit drug users or people with mental problems disproportionately curb the number of African-Americans and/or women eligible to participate in medical research, according to a new study from investigators at Stanford University. Lead researcher Keith Humphreys says the findings should encourage scientists who design studies to consider the unintended consequences of eligibility criteria. [click link for full article]

More: continued here

No Comments »

N.V. Organon, the human health care business unit of Akzo Nobel, and Royal Philips Electronics announced today that they will join forces in the development of new drugs and therapies for mental disorders and cancer. [click link for full article]

More: continued here

No Comments »

Giovanni Fava and Eliana Tossani of the University of Bologna review the literature on how depressive illness begins. Depression does not come out of the blue. There are clear warning signs that patients should know and allow an early intervention.The aim of this review was to survey the available literature on prodromal symptoms of unipolar major depression. Both a computerized (Medline) and a manual search of the literature were performed. [click link for full article]

More: continued here

No Comments »

The General Medical Council (GMC) has today launched a consultation to find out how doctors and patients can best work together to make decisions about treatment. The GMC is seeking the views of patients and doctors about draft guidance that sets out principles for good practice in making decisions. The guidance will, for the first time, provide advice for doctors on how to communicate the risks and possible side effects of treatment with patients. [click link for full article]

More: continued here

No Comments »

Millions of Americans take medications for hypertension but do not achieve control of their blood pressure. Single-tablet combinations of drugs may be what it takes to get blood pressure under control, even in people with moderate hypertension, according to results from a new international study involving more than 10,700 people with high blood pressure. [click link for full article]

More: continued here

No Comments »